Journal of Hepatocellular Carcinoma,
Journal Year:
2024,
Volume and Issue:
Volume 11, P. 1743 - 1761
Published: Sept. 1, 2024
This
study
aimed
to
identify
dendritic
cells
(DCs)
related
genes
in
hepatocellular
carcinoma
(HCC)
patients,
establish
DC-related
subtypes
and
signatures,
correlate
them
with
prognosis
treatment
response.
Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(17)
Published: Sept. 2, 2024
Sarcoidosis
is
a
multiorgan
granulomatous
disease
that
lacks
diagnostic
biomarkers
and
targeted
treatments.
Using
blood
skin
from
patients
with
sarcoid
non-sarcoid
granulomas,
we
discovered
granulomas
different
diseases
exhibit
unique
immune
cell
recruitment
molecular
signatures.
Sarcoid
were
specifically
enriched
for
type
1
innate
lymphoid
cells
(ILC1s)
B
exhibited
programs
associated
formation
of
mature
tertiary
structures
(TLSs),
including
increased
CXCL12/CXCR4
signaling.
Lung
sarcoidosis
also
displayed
similar
recruitment.
Thus,
granuloma
was
not
generic
response.
In
addition
to
tissue-specific
effects,
an
8-fold
increase
in
circulating
ILC1s,
which
correlated
treatment
status.
Multiple
types
induced
signaling
sarcoidosis,
Th1
T
cells,
macrophages,
ILCs.
Mechanistically,
CXCR4
inhibition
reduced
sarcoidosis-activated
migration,
targeting
or
total
ILCs
attenuated
noninfectious
mouse
model.
Taken
together,
our
results
show
ILC1s
are
tissue
biomarker
distinguishes
other
diseases.
Repurposing
existing
inhibitors
may
offer
new
this
devastating
disease.
Journal for ImmunoTherapy of Cancer,
Journal Year:
2025,
Volume and Issue:
13(2), P. e010824 - e010824
Published: Feb. 1, 2025
Immunotherapy
has
progressed
significantly
in
cancer
treatment;
however,
several
factors
influence
its
outcomes.
Abnormal
lipid
metabolism,
which
is
frequently
observed
cancers,
promotes
tumor
proliferation,
invasion,
and
metastasis.
Li
et
al
from
the
Medical
Oncology
Department
of
Chongqing
University
Cancer
Hospital
constructed
a
metabolism
scoring
system
reported
that
MK1775
inhibited
fatty
acid
oxidation
tumor-associated
macrophages
reduced
T-cell
infiltration,
further
enhancing
efficacy
immunotherapy.
This
study
demonstrated
critical
role
Currently,
lipids,
such
as
acids,
phospholipids,
cholesterol,
been
to
affect
microenvironment
by
regulating
immune
cells,
including
T
natural
killer
macrophages.
These
metabolic
changes
can
impair
immunotherapy,
resulting
progression.
Consequently,
emerges
an
important
regulator
for
improving
immunotherapeutic
outcomes
provides
novel
powerful
strategy
combination
therapy.
Antibodies,
Journal Year:
2025,
Volume and Issue:
14(1), P. 21 - 21
Published: March 3, 2025
Background:
Macrophages
play
an
important
role
in
eliminating
diseased
and
damaged
cells
through
programmed
cell
death.
Signal
regulatory
protein
alpha
(SIRPα)
is
a
crucial
immune
checkpoint
primarily
expressed
on
myeloid
macrophages.
It
initiates
‘do
not
eat
me’
signal
when
engaged
with
CD47,
which
typically
at
elevated
levels
multiple
solid
tumors.
The
phospholipase
A2
Group
7
(PLA2G7),
mainly
secreted
by
macrophages,
interacts
oxidized
low-density
lipoprotein
(oxLDL)
associates
several
vascular
diseases
cancers.
Methods:
To
identify
potent
fully
human
monoclonal
antibodies
(mAbs)
against
SIRPα
PLA2G7,
we
conducted
bio-panning
of
phage
antibody
libraries.
Results:
We
isolated
one
Fab
(1B3)
VH
(1A3)
for
SIRPα,
as
well
(1H8)
(1A9)
PLA2G7;
the
1B3
1A3
are
competitively
bound
to
interfering
CD47
binding.
IgG
VH-Fc
augmented
macrophage-mediated
phagocytic
activity
combined
anti-EGFR
antibody,
cetuximab.
anti-PLA2G7
exhibited
high
specificity
PLA2G7
antigen
effectively
blocked
enzymatic
half-maximal
inhibitory
concentrations
(IC50)
single-digit
nanomolar
range.
Additionally,
1H8
its
derivative
bispecific
ability
block
PLA2G7-mediated
tumor
migration.
Conclusions:
Our
anti-SIRPα
mAbs
expected
serve
inhibitors
enhancing
antitumor
responses
SIRPα-positive
cells.
Moreover,
our
represent
promising
blockade
potential
enhance
both
anti-tumor
anti-aging
responses.
Anti-SIRPα
can
modulate
macrophage
inflammatory
mBio,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 18, 2025
ABSTRACT
In
2022,
a
cluster
of
severe
childhood
hepatitis
was
detected
primarily
in
Europe
and
North
America,
leading
to
global
alert
by
the
World
Health
Organization.
An
association
with
adeno-associated
virus
2
(AAV2)
conjunction
human
adenoviruses
found.
Five
percent
cases
progressed
acute
liver
failure,
necessitating
transplantation.
The
mechanism
disease
that
accounts
for
fulminant
failure
these
patients
remains
incompletely
described.
upsurge
observed
five
total
presented
Dutch
national
referral
center
pediatric
transplantation
spring
2022.
in-depth
molecular
analysis
performed
using
targeted
transcriptomics
metagenomics
identify
any
present
cases,
immune
profile
haplotypes,
differentially
expressed
gene
groups.
Explanted
tissue
plasma
samples
(
n
=
15)
were
subjected
viral
metagenomic
transcriptomic
profiling,
targeting
>600
inflammatory
genes.
Liver
signatures
transplanted
compared
those
controls
from
biobank
6).
AAV2,
adenoviruses,
herpesviruses
explant
cases.
Epstein-Barr
varicella
zoster
infection
pathognomonic
clinical
symptomatology
preceded
two
respective
AAV2
one-third
control
livers.
Excessive
activation
monocyte
pathways
explants
controls.
Remarkably,
this
signature
comparable
and/or
herpesviruses-positive
transplant
Our
multi-omic
findings
suggest
common
profile,
an
upregulation
which
had
similar
outcomes.
cohort
presented,
not
exclusively
associated
suggesting
other
processes
may
have
contributed
uniform
cascade
irreversible
pathology.
IMPORTANCE
Since
appearance
unknown
origin
several
groups
reported
high
number
contrast
heterogeneous
both
species—adenovirus
C
F—and
sequences.
mechanisms
occurring
5%
remain
current
study
adds
previous
data
including
during
upsurge,
enabling
analyses
inflammation
expression
profiles
different
viruses
relation
This
led
discovery
transcriptome
Abstract
Osteosarcoma
(OS)
is
a
severe
malignancy
affecting
children
and
adolescents,
with
limited
effective
treatments
leading
to
poor
outcomes.
This
study
explored
the
potential
of
sporoderm-removed
Ganoderma
lucidum
spores
(RGLS)
as
novel
therapeutic
agent
against
OS
elucidated
its
mechanism
action.
Our
in
vivo
vitro
experiments
showed
that
RGLS
significantly
inhibited
S-180
cell
proliferation,
colony
formation,
migration,
while
simultaneously
inducing
apoptosis.
Multi-omics
analysis
revealed
disrupted
glycerophospholipid
metabolism
by
upregulating
lysophosphatidylcholine
(LysoPC)
levels
through
phospholipase
A2
(PLA2)-mediated
pathways.
Co-culture
assays
further
demonstrated
promoted
endocytosis
macrophage-derived
Pla2g7
protein
into
cells,
enhancing
anti-cancer
effects.
Additionally,
modulated
cellular
fatty
acid
profile
suppressed
β-oxidation
long-chain
acids,
energy
depletion
in
cells.
These
findings
provide
view
multi-targeted
mechanisms
RGLS,
positioning
it
promising
candidate
for
therapy.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(11), P. 5584 - 5584
Published: May 21, 2024
As
one
of
the
emerging
hallmarks
tumorigenesis
and
tumor
progression,
metabolic
remodeling
is
common
in
microenvironment.
Hepatocellular
carcinoma
(HCC)
third
leading
cause
global
tumor-related
mortality,
causing
a
series
alterations
response
to
nutrient
availability
consumption
fulfill
demands
biosynthesis
carcinogenesis.
Despite
efficacy
immunotherapy
treating
HCC,
rate
remains
unsatisfactory.
Recently,
research
has
focused
on
reprogramming
its
effects
immune
state
microenvironment,
rate.
In
this
review,
we
delineate
observed
HCC
influence
We
discuss
strategies
aimed
at
enhancing
rates
overcoming
resistance
through
interventions,
focusing
targeting
glucose,
lipid,
or
amino
acid
metabolism,
as
well
systemic
regulation.
OncoImmunology,
Journal Year:
2024,
Volume and Issue:
13(1)
Published: March 20, 2024
Colorectal
cancer
(CRC)
is
the
third
most
prevalent
worldwide
with
a
high
mortality
rate
(20-30%),
especially
due
to
metastasis
adjacent
organs.
Clinical
responses
chemotherapy,
radiation,
targeted
and
immunotherapies
are
limited
subset
of
patients
making
metastatic
CRC
(mCRC)
difficult
treat.
To
understand
therapeutic
modulation
immune
response
in
mCRC,
we
have
used
genetically
engineered
mouse
model
(GEMM),
"KPN",
which
resembles
human
'CMS4'-like
subtype.
We
show
here
that
transforming
growth
factor
(TGF-β1),
secreted
by
KPN
organoids,
increases
cell
proliferation,
inhibits
splenocyte
activation